Curaleaf Holdings (CURLF) Long-Term Investments (2019 - 2025)
Curaleaf Holdings (CURLF) posted quarterly Long-Term Investments of $263000.0 for Q4 2025, down 98.24% year-over-year from $15.0 million in Q4 2024, and down 98.24% quarter-over-quarter from $15.0 million in Q4 2024.
Curaleaf Holdings (CURLF) Long-Term Investments (2019 - 2025) Analysis & Trends
Curaleaf Holdings' Long-Term Investments history runs 7 years deep, the most recent figure standing at $263000.0 for Q4 2025.
- In Q4 2025, Long-Term Investments fell 98.24% year-over-year to $263000.0; the TTM figure through Dec 2025 stood at $263000.0 (down 98.24% YoY), while the FY2025 annual figure was $263000.0, down 98.24% from the prior year.
- Long-Term Investments for Q4 2025 stood at $263000.0, down from $15.0 million in the prior quarter.
- The five-year high for Long-Term Investments was $4.1 billion in Q1 2022, with the low at -$3.0 million in Q3 2024.
- The 5-year median for Long-Term Investments is $4.0 million (2021), against an average of $300.0 million.
- The sharpest annual moves came in 2022 and 2024: Long-Term Investments jumped 25164.39% in 2022, then tumbled 183.68% in 2024.
- Curaleaf Holdings' Long-Term Investments stood at $4.4 million in 2021, then slipped by 23.38% to $3.4 million in 2022, then jumped by 346.26% to $15.0 million in 2023, then dropped by 0.44% to $15.0 million in 2024, then plunged by 98.24% to $263000.0 in 2025.
- Business Quant data shows CURLF's Long-Term Investments at $263000.0 in Q4 2025, $15.0 million in Q4 2024, and -$3.0 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 92.58 Mn |
| 2 | Teva Pharmaceutical Industries | 43.28 Bn | 39.62 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.78 Bn | 30.11 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.71 Bn | 22.91 Bn | 5.10 Bn | 63.23 Mn |
| 5 | United Therapeutics | 22.25 Bn | 19.59 Bn | 683.80 Mn | 1.14 Bn |
| 6 | Viatris | 18.72 Bn | 17.83 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.57 Bn | 15.18 Bn | 935.80 Mn | 149.10 Mn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.97 Bn | - | 60.00 Mn |
| 10 | Curaleaf Holdings | 2.48 Bn | 2.38 Bn | 169.91 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 263,000.00 |
| Dec 31, 2024 | 14.98 Mn |
| Sep 30, 2024 | -2.99 Mn |
| Jun 30, 2024 | -92,000.00 |
| Dec 31, 2023 | 15.05 Mn |
| Sep 30, 2023 | 3.57 Mn |
| Jun 30, 2023 | 2.34 Mn |
| Sep 30, 2022 | 3.37 Mn |
| Jun 30, 2022 | 3.65 Mn |
| Mar 31, 2022 | 4.11 Bn |
| Dec 31, 2021 | 4.40 Mn |
| Sep 30, 2021 | 7.37 Mn |
| Jun 30, 2021 | 23.49 Mn |
| Mar 31, 2021 | 16.26 Mn |
| Dec 31, 2020 | 16.26 Mn |
| Sep 30, 2020 | 62.81 Mn |
| Dec 31, 2019 | 51.21 Mn |